Novel Targeted Agents in the Treatment of Multiple Myeloma - Hematology/Oncology Clinics
Frontiers | The Role of Proteasome Inhibitors in Treating Acute Lymphoblastic Leukaemia | Oncology
Development of Novel Epoxyketone-Based Proteasome Inhibitors as a Strategy To Overcome Cancer Resistance to Carfilzomib and Bortezomib | Journal of Medicinal Chemistry
Salinosporamide A - an overview | ScienceDirect Topics
Salinosporamide A - Wikipedia
The odyssey of marine pharmaceuticals: a current pipeline perspective: Trends in Pharmacological Sciences
Molecular Mechanisms of Acquired Proteasome Inhibitor Resistance | Journal of Medicinal Chemistry
Marizomib | C15H20ClNO4 - PubChem
Mechanisms mediating anti-MM activity of marizomib plus pomalidomide... | Download Scientific Diagram
Exploring the role and clinical implications of proteasome inhibition in medulloblastoma - Hoerig - 2021 - Pediatric Blood & Cancer - Wiley Online Library
Advances in the understanding of mechanisms and therapeutic use of bortezomib. - Abstract - Europe PMC
Frontiers | Soluble and Cell–Cell-Mediated Drivers of Proteasome Inhibitor Resistance in Multiple Myeloma | Endocrinology
Pomalidomide in the treatment of multiple myeloma: design, development | DDDT
Overcoming drug resistance by targeting protein homeostasis in multiple myeloma
Molecules | Free Full-Text | Proteasome Inhibitors: Harnessing Proteostasis to Combat Disease | HTML
Salinosporamide A - Wikipedia
Mechanism of Action of Bortezomib and the New Proteasome Inhibitors on Myeloma Cells and the Bone Microenvironment: Impact on Myeloma-Induced Alterations of Bone Remodeling
Structures of marizomib and its analogs and mechanism of proteasome... | Download Scientific Diagram
Salinosporamide A - Wikipedia
Drug Development Targeting the Ubiquitin-Proteasome System (UPS) for the Treatment of Human Cancers. - Abstract - Europe PMC
Proteasome Inhibitors, Refined | Science | AAAS
Salinosporamide A - Wikipedia
Advances in the understanding of mechanisms and therapeutic use of bortezomib. - Abstract - Europe PMC
